Join Tim Regan and Jesse Redmond as Jesse discusses the tumultuous year for cannabis and what to look for going into 2024. Then Tim talks to Robert Sassoon to gauge the outlook on psychedelics and the progress being made with psychiatric treatments.
Join Tim Regan and Jesse Redmond as Jesse discusses the tumultuous year for cannabis and what to look for going into 2024. Then Tim talks to Robert Sassoon to gauge the outlook on psychedelics and the progress being made with psychiatric treatments.